PGY-2 Critical Care Residency

Critical Care

Residency Program Director

Contact Information:
rlfirestone@ucdavis.edu 
UC Davis Health
Pharmacy Department
2315 Stockton Blvd, Room 1310
Sacramento, CA 95817

Rachelle Firestone, PharmD, BCCCP, FCCM
Senior Clinical Pharmacist, Critical Care
PGY2 Critical Care Residency Program Director
UC Davis Medical Center
Assistant Clinical Professor
UC San Francisco, School of Pharmacy

2024-2025 Residents:
Alex Kuo, PharmD
Spencer Hayashi, PharmD

ASHP Online Residency Directory

Program Purpose

PGY2 residency programs build upon Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advanced practice area, if available.

Program Goals and Objectives

See Required Competency Areas, Goals, and Objectives for Postgraduate Year Two (PGY2) Critical Care Pharmacy Residencies

Program Aim
The aim of the Critical Care Residency is to develop clinical pharmacists with the passion, perseverance, and skills to serve as integral member(s) of the critical care team and community. Graduates of the Program are expected to be leaders in the field through practice, research, and teaching.

Required Competency Areas, Goals, and Objectives

Learning Environment

The UC Davis Medical Center is an academic, tertiary care referral and Level I trauma center with over 116 licensed ICU beds, one of the highest proportions of ICU beds in the United States, and a reflection of the medical center's role as a major regional referral center for complex neurology, trauma, burns, and medical cases. There are seven, adult ICUs including medical, surgical, cardiology, cardiothoracic surgery, neurocritical care, and burns surgery. In addition the UC Davis Children’s Hospital is a world-class pediatric tertiary and quaternary care “hospital within a hospital” that includes a Neonatal Intensive Care Unit (NICU), Pediatric Intensive Care Unit (PICU), and Level 1 Pediatric Trauma Center.

The Department of Pharmacy Services at UC Davis Medical Center delivers well-established clinical programs to a range of medical and surgical services. Our critical care residents are embedded members of the multidisciplinary team that provides direct care to a diverse population of critically ill patients daily. The Critical Care Residency Program is individualized to meet each resident’s needs, taking into consideration previous clinical experiences and future professional goals.

Committee Involvement

The critical care residents serve as active members of the ICU Committee and Code Blue Committee. They provide regular reports on adverse drug events that occur in the ICU and collaborate with physicians, nurses, and respiratory therapists to improve pharmacotherapy systems for critically ill patients. Further, the residents deliver analysis and recommendations to the Pharmacy and Therapeutics Committee and Pain and Sedation Committee as requested.

Teaching & Learning Opportunities

The Critical Care Program offers many opportunities for both clinical and didactic teaching. In the clinical setting, critical care residents serve as co-preceptors for pharmacy students (UCSF), PGY1, and non-critical care PGY2 residents. In addition, residents participate in staff development/education (e.g., nursing, pharmacy, medical students, house staff) and provide routine patient education. Finally, residents may elect to deliver 1 – 2 lectures for the UC San Francisco and Touro University Schools of Pharmacy.

The Scholarship of Teaching and Learning Program (STLP) is an elective opportunity that prepares residents to become effective clinician educators. Residents participate in a series of interactive lectures and small group exercises that are designed to develop skills necessary to educate and train patients, caregivers, and healthcare providers. Requirements for successful completion of the STLP program include clinical precepting (30 hours), inter-professional education (1 hour), public outreach (1 hour), small group facilitation (4 hours), didactic teaching (2 hour), and ACPE-accredited peer-to-peer presentation (1 hour).

Rotation Opportunities:

Required Block Experiences (4-week)

Elective Block Experiences (4-week)

  • Surgical Intensive Care Unit I (SICU I)
  • Medical Intensive Care Unit I (MICU I)
  • Burns Surgery Service
  • Neurocritical Care Service
  • Surgical Intensive Care Unit II (SICU II)
  • Medical Intensive Care Unit II (MICU II)
  • Critical Care Pharmacy Triage
  • Pediatric Intensive Care Unit (PICU)
  • Cardiac Critical Care (CTICU, CCU)
  • Infectious Diseases (ID)
  • Emergency Medicine
  • Parenteral Nutrition*
  • Focused Research*
  • Toxicology*

Longitudinal Rotations (52 weeks, required)

  • Research and Scholarship
  • Practice Management

*typically, 2-week rotations

Staffing

Critical care residents are embedded members of the multidisciplinary critical care team (i.e.i.e., MICU, SICU, NCC, Burns) and train to provide comprehensive clinical and operational pharmacy services. Order verification and medication delivery are logical and expected extensions of bedside care. In practical terms, residents commonly translate their recommendations into provisional or “pended” orders in and order sets in EMR pending provider signature or rejection. They also provide prospective review and order verification. This closed-loop system of consultation, order verification, and medication delivery results in seamless bedside pharmacotherapy.

Operations staffing—beyond orientation and basic training—is integrated into the clinical role for each critical care service (e.g., MICU, SICU, NCC). In other words, clinical pharmacists are all expected to provide close operational support for critically ill patients. This role is focused on patients directly in the care of their team but includes cross-cover for other ICU services as needed.

Further, critical care residents participate in rapid and emergency response events (“code blue”) throughout the medical center. They are prepared through topic discussions and simulation labs and then supported (bedside) by a range of pharmacy staff with the goal of developing proficiency, confidence, and independence in this role.

The service requirement is clinical and operational support for an ICU service (e.g., MICU, SICU, NCC) every third weekend and 1 major holiday. Additionally, residents may be called upon to provide coverage for the clinical service for which they are currently on rotation and they independently staff the Critical Care Pharmacy Triage service.

Completion of competencies assigned to inpatient clinical pharmacists is expected, including BLS and ACLS.

Research and Scholarship

Research is an integral element of providing and improving patient care at UCDMC. The driving ambition is for practical, sustainable solutions to bedside problems. Challenges and questions are the natural product of endeavoring to practice beyond the bounds of current understanding. The practical purpose is to apply discoveries from the patient to the patient. The principal purpose is clinical practice improvement, guideline development, and publication and presentation.

Recent examples of our work

  • Falksen JA, Schomer KJ. Neurologic Examination Facilitated by Reversal of Rocuronium with Sugammadex. J Pharm Pract. 2024 Aug;37(4):880-884.
  • Vanderwyk K, Young S, Louie E, et al. ChoLecalciferol and ErgocAliferol Replacement iN CriTically InjurEd BuRN Patients: An Observational Cohort Study (LANTERN). J Burn Care Res. Published online July 27, 2024
  • Mangaoang IA, Schomer KJ, Firestone RL, et al. Mind the Gap: Estimated Duration of Inadequate Sedation After Rapid Sequence Induction and Intubation in Critically Ill Patients. CHEST Critical Care, 2024, 100089 In Press
  • Payne ML, Young S, Heard J, et al. Effect of dexmedetomidine on fluid resuscitation in burn-injured patients. J Burn Care Res. Published online March 9, 2024.
  • Falksen JA, Young SR, Lee JA. Comparison of Continuous Sedatives in the Burn ICU on Delirium and Coma. J Burn Care Res. 2024 Mar 4;45(2):410-415.
  • Derry KL, Duby JJ, Firestone RL, Li F, Box K, Atallah S, Eskandari A, Huang WT, Park JH, Schomer KJ, Vu L, Bakas ML, Nader N, Gross K, Caffarini E, Wimer D, Lee S, Lichtmann A, Grubbs J. Execution of an Effective Critical Care Pharmacist Collaborative in an Academic Health System. JACCP. 2023 May 26.
  • Falksen J, Young S, Lee J. Comparison of continuous sedatives in the Burn ICU on Delirium and Coma. Journal of Burn Care & Research. 2023.https://doi.org/10.1093/jbcr/irad164
  • Meckel JD, Benanti, GE, Schomer, KJ, Adams, JY, Parker, PL. Identification of medication classes associated with intensive care unit readmissions. J Am Coll Clin Pharm. 2023; 6( 7): 701- 708. doi:10.1002/jac5.1766
  • Hsu EH, Young S, Clayton N, Lee J, Hauser N, Penn B, Sen S. Disseminated Mycobacterium abscessus Infection in a Burn Patient. J Burn Care Res. 2022 May 17;43(3):742-745.
  • Coleman LE, Lee JA, Cocanour CS. Chapter 3: Management of Acute Pain in the Intensive Care Unit. In: Vincent JL, Moore F, Bellomo R, Marini J, eds. Textbook of Critical Care. 8th ed. Elsevier; 2022:13-19.
  • Louie E, Young S, Virk M, Barsun A, Sen S. Topical Liposomal Amphotericin (Ambisome®) for the Treatment of Cutaneous Fusarium in a Burn-Injured Patient. J Burn Care Res. 2023 Jan 5;44(1):207-209.
  • Somani ST, Firestone RL, Donnelley MA, Sanchez L, Hatfield C, Fine J, Wilson M, Duby JJ. Impact of Vaccination on Cost and Course of Hospitalization Associated with COVID-19 Infection. Antimicrobial Stewardship & Healthcare Epidemiology. 2023 Jan 25;3(1):e19.
  • Hua CT, Firestone RL, Duby JJ. Effect of Insulin Delivery Strategies on Glycemic Control and Nursing Exposure in Critically Ill Patients With COVID-19: An Observational Cohort Study. Diabetes Care. 2022 Aug 10: dc212602.
  • Falksen JA, Duby JJ, Wilson MD, Fine JR, Cocanour CS. Effect of Delay and Disruption in Venous Thromboembolism Prophylaxis in Trauma Patients: Case-Control Study. J Am Coll Surg. 2022 Jul 1;235(1):34-40.
  • Summers A, Singh J, Lai M, Schomer KJ, Martin R, Vitt JR, Derry KL, Box K, Chu F, Arias V, Minokadeh A, Stern-Nezer S, Groysman L, Lee BJ, Atallah S. A multicenter retrospective study evaluating the impact of desmopressin on hematoma expansion in patients with antiplatelet-associated intracranial hemorrhage. Thromb Res. 2023 Feb;222:96-101.
  • Schonenberger S, Tesoro EP, Meza M, Stoianovici R. Acute Ischemic Stroke. In: Neurocritical Care ON CALL. https://learn.neurocriticalcare.org/courses/44788
  • Dhar R, Stoianovici R, Zeeman J, Kramer C. Acute Neuromuscular Disorders. In: Neurocritical Care ON CALL. https://learn.neurocriticalcare.org/courses/44788
  • Hua CT, Firestone RL, Duby JJ. Effect of Insulin Delivery Strategies on Glycemic Control and Nursing Exposure in Critically Ill Patients With COVID-19: An Observational Cohort Study. Diabetes Care. 2022 Aug.
  • Verkerk BS, Lesch C, Cham S, Berger K. Cryoprecipitate for Alteplase-Related Hemorrhagic Conversion of Acute Ischemic Stroke. J Pharm Pract. 2022; May.
  • Verkerk B, Lam T, Firestone RL, Duby JJ, Schirin Tang. Intensity of Therapeutic Paralysis in ARDS Does Not Correspond with Lung-Protective Ventilation. Critical Care Medicine: 2022: 50(1):544-544.
  • Coleman LE, Lee JA, Cocanour CS. Chapter 3: Management of Acute Pain in the Intensive Care Unit. In: Vincent JL, Moore F, Bellomo R, Marini J, eds. Textbook of Critical Care. 8th ed. Elsevier; 2022:13-19
  • Falksen JA, Duby JJ, Wilson MD, Fine JR, Cocanour CS. Effect of Delay and Disruption in Venous Thromboembolism Prophylaxis in Trauma Patients: Case-Control Study. J Am Coll Surg. 2022 Jul 1;235(1):34-40
  • Hsu EH, Young S, Clayton N, Lee J, Hauser N, Penn B, Sen S. Disseminated Mycobacterium abscess Infection in a Burn Patient. J Burn Care Res. 2022 May 17;43(3):742-745.
  • Schlobohm CJ, Zhu E, Duby JJ. Continuous infusion versus intermittent infusion vancomycin in a burn center intensive care unit. Burns. 2021 Nov;47(7):1495-1501.
  • Young SR, Duby JJ, Louie EL, Palmieri TL. Impact of Multimodal Analgesia in Critically Ill Burn Patients. J Burn Care Res. 2021 Sep 30;42(5):986-990
  • Rife T, Zhao M, Im J, Pennington D. Evaluating implementation of a combination opioid and benzodiazepine new start consult at the San Francisco Veterans Affairs Health Care System. J Am Coll Clin Pharm. 2021; 4(7):808-818.
  • Duby JJ, Schomer KJ, Oyewole V, Christian V, Young SR. Norepinephrine Dosing Error Associated with Multiple Health System Vulnerabilities. PSNet. May 2021.
  • Kulig CE, Schomer KJ, Black HB, Dager WE. Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients. ASAIO J. 2021 Apr 1;67(4):411-415.
  • Stoianovici R, Brunetti L, Adams CD. Comparison of Melatonin and Zolpidem for Sleep in an Academic Community Hospital: An Analysis of Patient Perception and Inpatient Outcomes. J Pharm Pract. 2021 Feb;34(1):44-50.
  • Castillo R, Chan A, Atallah S, Derry K, Baje M, Zimmermann LL, Martin R, Groysman L, Stern-Nezer S, Minokadeh A, Nova A, Huang W, Cang W, Schomer K. Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products. J Thromb Thrombolysis. 2021 Jan;51(1):151-158.
  • Fazio S and Firestone RL. Fatal Patient-Controlled Analgesia (PCA) Opioid-Induced Respiratory Depression. PSNet. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 2020.
  • Schomer KJDuby JJ; Firestone RL, Louie EL, Sebat CM, Love DM, Cocanour CS, Albertson TE.  Effect of Flumazenil on Hypoactive Delirium in the ICU: A Double-Blind, Placebo-Controlled Pilot Study. Critical Care Explorations. 2(3): e0085, March 2020.
  • Haratipour P, Minard C, Nakhjiri M, Negahbani A, Chamberlain B, Osuna J, Upton T, Zhao M, Kashemirov B, McKenna C. Completing the β,γ-CXY-dNTP stereochemical probe tool-kit: Synthetic access to the dCTP diastereomers and 31P and 19F NMR correlations with absolute configurations. J Org Chem. 2020;85(22):14592-14609.
  • Korzewski M, Madden L, Schomer K, Van Leuven, K. Heparin Flush Use in Transfemoral Cerebral Angiography Survey. Journal of Radiology Nursing. 2020 Sept; 39(3): 199-206.
  • Dzierba AL, Pedone T, Patel MK, Ciolek A, Mehta M, Berger K, Ramos LG, Patel VD, Littlefield A, Chuich T, May HB, Muir J, Verkerk BS, Poon T, Der-Nigoghossian C, Nikolos P, Gunther M, Shah J, Witenko CJ. Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID-19. J Am Coll Clin Pharm. 2020 Aug 12.
  • Verkerk BS, Berger K, Lesch CA. Aminocaproic Acid for the Reversal of Alteplase: A Case Series. J Pharm Pract. 2020 Dec;33(6):919-925.
  • Wright M, Lee JA. Multimodal Analgesia and Discharge Opioid Requirements in Burn Patients. J Burn Care Res. 2020 Sep 23;41(5):963-966.
  • Lee JA, Erstad BL, Mir HR. Pharmacologic Analgesia. In: American College of Surgeons Trauma Quality Programs Best Practices Guidelines for Acute Pain Management in Trauma Patients. Nov 2020.
  • Fazio S and Firestone RL. Fatal Patient-Controlled Analgesia (PCA) Opioid-Induced Respiratory Depression. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 2020.
  • Hwang T, Alvarez A, Morris A, Li F, Caffarini E, Meckel J, Firestone RL, Kohn M, Chang S. Evaluation of Angiotensin II Versus Usual Care in the Treatment of Refractory Vasodilatory Shock. Critical Care Medicine. 49(1):182, January 2021. SCCM Research Snapshot 385.
  • Narayanan N, Adams CD, Kubiak DW, Cheng S, Stoianovici R, Kagan L, Brunetti L. Evaluation of treatment options for methicillin-resistant Staphylococcus aureusinfections in the obese patient. Infect Drug Resist. 2019 Apr 17;12:877-891.
  • Firestone RL, Parker PL, Pandya KA, Wilson MD, Duby JJ. Moderate-Intensity Insulin Therapy Is Associated with Reduced Length of Stay in Critically Ill Patients with Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State. Crit Care Med. 2019 Mar 7.
  • Hamrick KL, Beyer CA, Lee JA, Cocanour CS, Duby JJ. Multimodal Analgesia and Opioid Use in Critically Ill Trauma Patients. J Am Coll Surg. 2019 Feb 20.
  • Lee JA, Duby JJ, Cocanour CS. Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome. Clin Toxicol (Phila). 2019 Feb 7:1-4.
  • Bouajram RH, Sebat CM, Love D, Louie EL, Wilson MD, Duby JJ. Comparison of Self-Reported and Behavioral Pain Assessment Tools in Critically Ill Patients. J Intensive Care Med. 2018; Jan 1.

  • Fusarium spp Isolates in Burn-Injured Patients: Clinical Characteristics and Susceptibility Patterns. American Burn Association Annual Meeting. April 2024. Awarded "Best in Category". (Sierra Young, Erin Louie, Robyn Stoianovici, Jeremiah Duby)
  • Predictive Values of Methicillin-Resistant Staphylococcus aureus Nasal Swabs for Pneumonia in Burn ICU Patients. American Burn Association Annual Meeting. April 2024. (Zac Carlson, Sierra Young, Erin Louie, Robyn Stoianovici, Jeremiah Duby)
  • Pharmacy Experiential Precepting in the Era of Artificial Intelligence (AI). University of California Preceptor Development Series. April 2024. (Sierra Young)
  • 12 (or So) Steps for Putting "Happy" Back in "Happy Hour": Strategies for Alcohol Withdrawal. Annual Congress. Society of Critical Care Medicine. January 2024. (Jeremiah Duby, Jin Lee)
  • Clinical Pharmacist-driven Electronic Data Capture of Medication Administration Records in the ELECTRO-BOOST Multicenter Study. 21st Neurocritical Care Society Annual Meeting. August 2023. (Robyn Stoianovici)
  • Novel Agents for Multimodal Pain Management in Critically Ill Patients. Annual Congress. Society of Critical Care Medicine. January (Jeremiah Duby)
  • Blood Pressure Reduction and Risk of Acute Kidney Injury in Patients with Aortic Syndromes. Research Snapshot Theater. Annual Congress. Society of Critical Care Medicine. January 2023. (Emily Hsu, Jeremiah Duby)
  • Effect of Gabapentin and Methocarbamol on Length of Stay in Patients with Traumatic Rib Fractures. Research Snapshot Theater. Annual Congress. Society of Critical Care Medicine. January 2023. (Jin Lee, Sierra Young, Jeremiah Duby)
  • Impact of Vaccination on Cost and Course of Hospitalization Associated with COVID-19 Infection. Research Snapshot Theater. Annual Congress. Society of Critical Care Medicine. January 2023. (Selina Somani, Rachelle Firestone, Jeremiah Duby)
  • Respiratory Devices for Inpatient Management: A Primer for Clinical Pharmacists. Pulmonary PRN Focus Session. ACCP Global Conference on Clinical Pharmacy. October 2022. (Brittany Verkerk)
  • Gen Z, The Next Generation - Where No Preceptor Has Gone Before.American Society of Health-System Pharmacists, National Pharmacy Preceptors Conference., October 2022. (Rachelle Firestone)
  • Self-guided, online learning activity. Defining Authorship and Contributorship. Research Skills Certificate. ASHP. https://elearning.ashp.org/products/9795/research-skills-certificate. May 2022 - Present. (Jeremiah Duby)
  • Self-guided, online learning activity. Introduction to Title and Abstract Writing. Research Skills Certificate. ASHP. https://elearning.ashp.org/products/9795/research-skills-certificate. May 2022 - Present. (Jeremiah Duby)
  • Self-guided, online learning activity. How to Build Tables and Graphs. Research Skills Certificate. ASHP. https://elearning.ashp.org/products/9795/research-skills-certificate. May 2022 - Present. (Jeremiah Duby)
  • Gen Z The Next Generation - Where No Preceptor Has Gone Before. California Society of Health-System Pharmacists, Pacific Coast Preceptor Conference May 2022. (Rachelle Firestone)
  • Implications of Vitamin D During Critical Illness. Annual Congress. Society of Critical Care Medicine. April (Jeremiah Duby)
  • Continuous Versus Noncontinuous Glucose Monitoring - Other Factors That Affect Your Glucose.. 50th Critical Care Congress, Society of Critical Care Medicine. February 2020. (Rachelle Firestone)
  • Recurrent INR Rebound After Warfarin Reversal in the Setting of Traumatic Intracranial Hemorrhage.Research Snapshot Theater. 50th Critical Care Congress, Society of Critical Care Medicine. February 2020. (Robyn Stoianovici)
  • Impact of Multimodal Analgesia on Critically Ill Burn Patients. 52nd Annual Meeting. American Burn Association. 2020. (Sierra Young)
  • Hypertonic sodium chloride versus combination hypertonic sodium chloride and sodium acetate in patients with traumatic brain injury. 48th Society of Critical Care Medicine Critical Care Congress; February 2019 (Robyn Stoianovici).
  • Bedside Pharmacologic Management. Bedside Pharmacological Management. Pre-Congress Symposium. Critical Care Congress. Society of Critical Care Medicine. Jeremiah Duby (program coordinator and moderator)
  • Focusing Fire or Watchful Waiting: Substance Withdrawal in the ICU. Pre-Congress Symposium. Critical Care Congress. Society of Critical Care Medicine. (Jeremiah Duby)
  • Understanding and Navigating the Realities of Drug Shortages in the ICU. Roundtable Topic Discussion.  Critical Care Congress. Society of Critical Care Medicine. Jeremiah Duby (topic facilitator).
  • How We Miss Withdrawal in the ICU. Critical Care Congress. Society of Critical Care Medicine. (Jeremiah Duby)

  • Fellow of Critical Care Medicine (FCCM). Society of Critical Care Medicine.
    • Jeremiah Duby (2019)
    • Rachelle Firestone (2024)
    • Kendra Schomer (2025)
  • Early Career Investigator Award, Society of Critical Care Medicine. Clinical Pharmacy and Pharmacology Section.
    • Isabel Mangaoang
  • 2023 Apple for Excellence in Teaching Award
    • Sierra Young
    • Jeremiah Duby
    • Robyn Stoianovici
  • Presidential Citation. Society of Critical Care Medicine. 2023.
    • Jeremiah Duby
  • Nursing Excellence Award. UC Davis Health. 2023.
    • Rachelle Firestone (2)
    • Jessica Falksen
  • UCDH Medication Safety Catch of the Year. 2022.
    • Jessica Falksen
  • UC San Francisco School of Pharmacy’s Class of 2022 Apple for Excellence in Teaching Award
    • Rachelle Firestone
    • Jeremiah Duby
  • UC San Francisco School of Pharmacy’s Master Preceptor Program
    • Rachelle Firestone (2022)
    • Sierra Young (2024)
  • UCD Healthcare Quality Forum High Value Care Award March 2022
    • Kendra Schomer
  • UC Davis Health Excellence Award, March 2022
    • Rachelle Firestone
  • Presidential Citation. Society of Critical Care Medicine. Spring 2021.
    • Jeremiah Duby
  • Most Impactful Research Project. UC Pharmacy Collaborative Conference. Spring 2021.
    • Tommy Lam (PGY1 resident), Brittany Verkerk (primary preceptor)
  • Nursing Excellence Award. UCDH. Spring 2021.
    • Jeremiah Duby
    • Kendra Schomer
  • Great Catch of the Year Award. UCDH. Spring 2021.
    • Robyn Stoianovici
  • The Daisy Foundation United in Caring team award. Medical ICU team. UCDH. Fall 2020.
    • Rachelle Firestone
  • Presidential Citation. Society of Critical Care Medicine. Spring 2020.
    • Jeremiah Duby
  • Best Research Design. Multimodal analgesia and discharge opioid requirements in burn patients. UC Collaborative Conference. 
    • Michael Wright (PGY1), Jin Lee (primary preceptor)
  • Best in Category Award: Critical Care. Impact of a Bundled Approach to Procedural Pain Management in Burn Patients. Annual Meeting. American Burn Association.
    • Sierra Young (PGY1), Erin Louie (primary preceptor), Jeremiah Duby
  • Most Impactful Research Project. Impact of Multimodal Analgesia in Critically Ill Burn Patients.  UC Collaborative Conference.
    • Sierra Young (PGY2), Erin Louie (primary preceptor), Jeremiah Duby
  • Presidential Citation. Society of Critical Care Medicine. Spring 2018.
    • Jeremiah Duby

Appointment period: July 1 to June 30

Number of positions: 2

Stipend: $77,000 per year (paid monthly)

Fringe Benefits: 
Health, Dental and Vision insurance for resident and dependents; vacation, sick leave and professional leave as outlined in the Pharmacy Resident Manual, usually 21 days of PTO, 14 paid holidays, 6 extended sick days and 4 days of professional development leave.  Travel funds (~$3000) are included in the base salary. There is a stipend for Pharmacy Department scrubs.

Use of sick leave is subject to approval by the RPD.

Resident Personnel Policies:
The following policies can be located in the Pharmacy Resident Personnel Manual

  • Resident Qualifications
  • Licensure policy
  • Leave policies
  • Early Commitment Policy
  • Pre-employment Requirements
  • Health insurance and Benefits
  • Moonlighting
  • Duty hours/tracking of duty hours
  • Dismissal policy and consequences of failure to progress

Requirements for Successful Completion of the Residency

Requirements

  • California Pharmacist Licensure Per Pharmacy Resident Manual Policy
  • A minimum of 52-weeks training inclusive of standard vacation, professional, and sick leave
    • Completion of the Appendix to Required Competency Areas, Goals, And Objectives for Postgraduate Year Two (PGY2) Critical Care Pharmacy Residencies
    • Completed Duty Hours log
  • Completion of assigned competencies, including ACLS
  • Completion of staffing contributions as outlined by the residency program description
  • Completion of all required rotations/learning experiences
    • No outstanding “Needs Improvement” on any required rotation goals or objectives
    • Minimum of 80% of objectives marked as “Achieved” by the end of the residency year
    • 100% of Patient Care Competency Area R1
  • Completion of research project (IRB approval, complete abstract/manuscript, closeout if data collection complete)
  • Completed institutional protocol, guideline, or monograph
  • Presentation of research project at UC Pharmacy Conference (regional research conference)
  • Attendance at second pharmacy conference (to be in area of resident interest)
  • Complete and deliver Grand Rounds (or equivalent) to selected audience
  • Active participation in committee meetings and projects as assigned
  • Active participation in annual residency program CQI meeting
  • Completed end-of-year self-assessment
  • Exit interview with RPD and completed resident closeout in PharmAcademic 

Expectations

  • Timely completion of Pharm Academic evaluations and co-signatures
  • Join a professional organization with a mission, initiative, or concerted effort to further critical care practice (SCCM)
  • Use of PTO must be arranged with RPD in advance of start of rotation (with exception of extenuating circumstances or illness). Preceptor notification must be in advance of assigned learning experience for planned leave 

Pharmacy Residency training programs at UC Davis Health are conducted under the licensed entity within UC Davis Health which is UC Davis Medical Center.